Search - tctmd.com

Displaying 601 - 620 of 824

Sort: Relevancy | Date

News Industry News

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

November 10, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

Presentation

LVAD Therapy in End-Stage Heart Disease

Presenter: Matthias Loebe

October 30, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

October 12, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Industry News

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

October 06, 2015

Advertisement

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

Post-TAVR Myocardial Injury Linked to Mortality

LVAD Therapy in End-Stage Heart Disease

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Asian TAVR Registry Shows Good Procedural and Clinical Results

Boston Scientific Announces Scheduled Presentations At TCT 2015

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content